Related references
Note: Only part of the references are listed.Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S. Chheda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Considerations for successful cancer immunotherapy in aged hosts
Vincent Hurez et al.
EXPERIMENTAL GERONTOLOGY (2018)
Dendritic Cell-Based Cancer Vaccines
Patricia M. Santos et al.
JOURNAL OF IMMUNOLOGY (2018)
Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen et al.
NATURE IMMUNOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
Tae Kon Kim et al.
TRENDS IN IMMUNOLOGY (2018)
Targeting Resident Memory T Cells for Cancer Immunotherapy
Charlotte Blanc et al.
FRONTIERS IN IMMUNOLOGY (2018)
Radiation and Anti-Cancer Vaccines: A Winning Combination
Alexandra Cadena et al.
VACCINES (2018)
Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B. S. Roden et al.
NATURE REVIEWS CANCER (2018)
Designing therapeutic cancer vaccines by mimicking viral infections
Hussein Sultan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Antitumor Effect of a DNA Vaccine Harboring Prostate Cancer-Specific Antigen with IL-12 as an Intramolecular Adjuvant
Yu Yang et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
Sanja Stevanovic et al.
SCIENCE (2017)
Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant
Willem W. Overwijk
CURRENT OPINION IN IMMUNOLOGY (2017)
Cancer immunotherapy: moving forward with peptide T cell vaccines
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Peptide vaccines in cancer - old concept revisited
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
mRNA: A Versatile Molecule for Cancer Vaccines
Mustafa Diken et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2017)
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
Qiong J. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication
Omar A. Ali et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Vaccine based immunotherapy regimen (VBIR) for the treatment of prostate cancer
Helen Cho et al.
CANCER RESEARCH (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+cervical intraepithelial neoplasia 2/3 (CIN2/3)
Ronald D. Alvarez et al.
GYNECOLOGIC ONCOLOGY (2016)
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
Elisabeth Quoix et al.
LANCET ONCOLOGY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice
Stefanie N. Linch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Marij J. Welters et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
S. H. T. Jorritsma et al.
VACCINE (2016)
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd D. Prickett et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines
Spencer D. Martin et al.
PLOS ONE (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Supramolecular peptide vaccines: tuning adaptive immunity
Yi Wen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes-Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
Evan J. Lipson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
DNA vaccines, electroporation and their applications in cancer treatment
Si-Hyeong Lee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Immunoprevention of Human Papillomavirus-Associated Malignancies
Joshua W. Wang et al.
CANCER PREVENTION RESEARCH (2015)
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
Emanuela Romano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Messenger RNA (mRNA) nanoparticle tumour vaccination
Kyle K. L. Phua et al.
NANOSCALE (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
Tae Jin Kim et al.
NATURE COMMUNICATIONS (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
Laurence M. Wood et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
Amy E. Moran et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
Rodney A. Rosalia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Live-attenuated bacteria as a cancer vaccine vector
Bertrand Toussaint et al.
EXPERT REVIEW OF VACCINES (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
Kyle K. L. Phua et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non-Self-Tumor Antigens: Implications for Cancer Immunotherapy
Sara R. Pedersen et al.
JOURNAL OF IMMUNOLOGY (2013)
The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer
Kousaku Mimura et al.
JOURNAL OF IMMUNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy
Sebastien Anguille et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
Suzanne van Duikeren et al.
JOURNAL OF IMMUNOLOGY (2012)
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel et al.
LANCET ONCOLOGY (2012)
Understanding and learning from the success of prophylactic human papillomavirus vaccines
John T. Schiller et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naive Prostate Cancer Patients
Julia Karbach et al.
CLINICAL CANCER RESEARCH (2011)
Epidermal Growth Factor Receptor Inhibition Augments the Expression of MHC Class I and II Genes
Brian P. Pollack et al.
CLINICAL CANCER RESEARCH (2011)
Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
S. Cecco et al.
CURRENT CANCER DRUG TARGETS (2011)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas
Olivera J. Finn et al.
IMMUNOLOGIC RESEARCH (2011)
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Xingfang Su et al.
MOLECULAR PHARMACEUTICS (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
Beom Kyung Kim et al.
ONCOLOGY (2011)
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
James L. Gulley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Seromic profiling of ovarian and pancreatic cancer
Sacha Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model
Maria R. Sorensen et al.
VACCINE (2010)
Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
Hyun-Il Cho et al.
CANCER RESEARCH (2009)
Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells
Hongwei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Adenovirus MART-1 - engineered autologous dendritic cell vaccine for metastatic melanoma
Lisa H. Butterfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Genome-wide analysis of cancer/testis gene expression
Oliver Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M. Arlen et al.
JOURNAL OF UROLOGY (2007)
Granulocyte macrophage colony-stimulating factor-secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer
Eric J. Small et al.
CLINICAL CANCER RESEARCH (2007)
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:: a combined analysis of four randomised clinical trials
L. Villa et al.
LANCET (2007)
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Cationic lipids, lipoplexes and intracellular delivery of genes
Luc Wasungu et al.
JOURNAL OF CONTROLLED RELEASE (2006)
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen
S Murata et al.
JOURNAL OF IMMUNOLOGY (2006)
A phase I trial of pox PSA vaccines (PROSTVAC®-VF) with b7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in patients with prostate cancer -: art. no. 1
RS DiPaola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors
LG Bermúdez-Humarán et al.
JOURNAL OF IMMUNOLOGY (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells
DA Saltzman
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
EM Janssen et al.
NATURE (2005)
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines
SR Little et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma
R Salgia et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo
T De Smedt et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
